North America Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)
Market Introduction
North America consists of three major countries, namely the US, Canada, Mexico. The market is also evaluated for the Rest of the North American market. The growth of the market in countries such as the US and Canada is driven by the factors such as increasing demand for pharmaceutical intermediate to produce APIs, growing support supports through an initiative to enhance pharmaceutical production, and rising research and development for the biopharmaceutical industry. Also, the growing pharmaceutical industry in a country like Mexico is expected to serve the market's growth opportunities during the forecast period. The US is the largest market for pharmaceutical intermediates at a global level. The market's growth is attributed to increasing product development, increasing production of generic pharmaceutical production, and growing government support to enhance pharmaceutical and biopharmaceutical industries. In addition, the growing incidences of chronic and acute diseases have led to the growth of the market indirectly. Increased prevalence of chronic diseases and infectious diseases is the major factor driving the growth of the North America pharmaceutical intermediates market.
North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 31,990,143, with 576,298 deaths reported in the US as of April 2021. The cases are also increasing in Mexico and Canada. In Mexico, the cases have reached 2,281,840, with 209,702deaths as of April 2021. Similarly, in Canada, there are about 1,071,016 COVID cases, reported as of April 2021. The pandemic is straining public health systems globally, interrupting and delaying many kinds of critical health care. A recent survey by the World Health Organization found that health services are among the most frequently disrupted. 7 in 10 countries around the world are experiencing disruptions along with United states, Canada and Mexico. However, as per the IRI data, demand for various dietary supplements rushed at the onset of the coronavirus pandemic in the U.S. at unprecedented rates. The total supplement sales increased by 6% during the first week of March, 2020. Also, due to social distancing practices consumers are experiencing changes to their daily routines of grooming and skin care. This has led to an increased demand for nutrition products that can be used at home. Also, the rising incidence of COVID patients has increased the demand for analgesics in the North America region.
Get more information on this report :
Market Overview and Dynamics
The pharmaceutical intermediates market in North America is expected to grow from US$ 11,054.47 million in 2021 to US$ 14,927.32 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028. Countries such as Mexico is emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Low manufacturing and operating costs in the country are key factors driving the pharmaceutical manufacturing business in the region. Recent growth in the pharmaceutical industry indicate a positive outlook for the pharmaceutical intermediates market. Flourishing domestic pharmaceutical market in the region and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities, further boosting the growth of the market. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies across North America region.
Key Market Segments
The North America pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; Sanofi; Vertellus Holdings LLC are among others.
Reasons to buy report
- To understand the North America pharmaceutical intermediates market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America pharmaceutical intermediates market
- Efficiently plan M&A and partnership deals in North America pharmaceutical intermediates market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America pharmaceutical intermediates market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Pharmaceutical Intermediates Market Segmentation
North America Pharmaceutical Intermediates Market -By Type
- GMP
- Non GMP
North America Pharmaceutical Intermediates Market -By Application
- Antibiotics
- Antipyretic analgesics
- Vitamins
- Others
North America Pharmaceutical Intermediates Market -By Distribution Channel
- Distributor
- Direct Sales
North America Pharmaceutical Intermediates Market -By Country
- US
- Canada
- Mexico
North America Pharmaceutical Intermediates Market -Company Profiles
- BASF SE
- chiracon GmbH
- Codexis
- Dishman Carbogen Amcis Ltd
- Midas Pharma GmbH
- Pfizer Inc.
- Sanofi
- Vertellus Holdings LLC
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Pharmaceutical Intermediates Market – By Type
1.3.2 North America Pharmaceutical Intermediates Market – By Application
1.3.3 North America Pharmaceutical Intermediates Market – By Distribution Channel
1.3.4 North America Pharmaceutical Intermediates Market– By Country
2. North America Pharmaceutical Intermediates Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Pharmaceutical Intermediates Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Pharmaceutical Intermediates Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases
5.1.2 Escalating R&D Investments by Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Price of Manufacturing
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Surge in Adoption of AI-based Tools for Drug Discovery
5.5 Impact Analysis
6. Pharmaceutical Intermediates Market– North America Analysis
6.1 North America Pharmaceutical Intermediates Market Revenue Forecast and Analysis
7. North America Pharmaceutical Intermediates Market Analysis – By Type
7.1 Overview
7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
7.3 GMP
7.3.1 Overview
7.3.2 GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Non GMP
7.4.1 Overview
7.4.2 Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8. North America Pharmaceutical Intermediates Market Analysis – By Application
8.1 Overview
8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
8.3 Antibiotics
8.3.1 Overview
8.3.2 Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Antipyretic Analgesics
8.4.1 Overview
8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Vitamins
8.5.1 Overview
8.5.2 Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9. North America Pharmaceutical Intermediates Market– By Distribution Channel
9.1 Overview
9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
9.3 Distributor
9.3.1 Overview
9.3.2 Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Direct Sales
9.4.1 Overview
9.4.2 Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
10. North America Pharmaceutical Intermediates Market – Country Analysis
10.1.1 Overview
10.1.2 North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.1.3 US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 US: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.3.3 US: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.3.4 US: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Canada: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.4.3 Canada: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.4.4 Canada: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.5 Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 Mexico: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.5.3 Mexico: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.5.4 Mexico: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Pharmaceutical Intermediates Market
11.1 Overview
12. Pharmaceutical Intermediates Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BASF SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Dishman Carbogen Amcis Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Codexis
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Midas Pharma GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 chiracon GmbH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Vertellus Holdings LLC
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)
Table 2. US Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments Done By Companies
Table 12. Inorganic Developments Done By Companies
Table 13. Glossary of Terms, Pharmaceutical Intermediates Market
LIST OF FIGURES
Figure 1. North America Pharmaceutical Intermediates Market Segmentation
Figure 2. North America Pharmaceutical Intermediates Segmentation, By Country
Figure 3. North America Pharmaceutical Intermediates Market Overview
Figure 4. GMP Held Largest Share of Type Segment in North America Pharmaceutical Intermediates Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Expert Opinion
Figure 8. North America Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints
Figure 9. North America Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
Figure 11. North America GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
Figure 14. North America Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
Figure 19. North America Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 22. North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 23. US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Impact of COVID-19 Pandemic in North American Country Markets
- BASF SE
- chiracon GmbH
- Codexis
- Dishman Carbogen Amcis Ltd
- Midas Pharma GmbH
- Pfizer Inc.
- Sanofi
- Vertellus Holdings LLC
- players and segments in the North America Pharmaceutical Intermediates market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Pharmaceutical Intermediates market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Pharmaceutical Intermediates market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution